Although FAP typically manifests in adulthood, understanding its genetic basis is crucial in the context of neonatal disorders. Early identification of the TTR gene mutation can help in managing potential complications and planning long-term care strategies for the child. Genetic screening for families with a history of FAP can be beneficial in identifying carriers and affected individuals early on.
